Adenosine Injection USP

Description:
Adenosine Injection USP is a pharmaceutical-grade solution, with a concentration of 3 mg/ml, designed to address specific cardiac conditions and diagnostic procedures. This sterile injectable medication is formulated with precision to meet the rigorous standards of the United States Pharmacopeia (USP). Adenosine, the active ingredient, plays a crucial role in the regulation of heart rhythm, making this injection an invaluable tool in cardiology.

Indication:
Adenosine Injection USP is indicated for the conversion of paroxysmal supraventricular tachycardia (PSVT) to normal sinus rhythm. It is employed as a diagnostic agent during certain cardiac imaging procedures, aiding in the identification and evaluation of coronary artery disease. Healthcare professionals may administer Adenosine Injection as part of a carefully managed treatment plan.

Dosage and Administration:
The dosage of Adenosine Injection is determined by the prescribing physician or cardiologist based on the patient’s medical condition and the specific diagnostic or therapeutic goals. The injection is administered intravenously by trained healthcare professionals in a controlled clinical setting. Dosage adjustments may be made to achieve the desired cardiovascular response.

Packaging:
Adenosine Injection USP is conveniently packaged in vials, ensuring accurate dosing and ease of administration. The vials are designed to maintain the sterility and stability of the product, safeguarding its efficacy during storage and use. This presentation facilitates the integration of Adenosine Injection into healthcare practices, offering a reliable solution for cardiovascular management.

Disclaimer:
This product information is intended for healthcare professionals and should not be used as a substitute for professional medical advice. Patients are advised to consult their healthcare providers for personalized guidance on the use of Adenosine Injection USP. This information may be subject to updates, and users are encouraged to verify the latest details from the pharmaceutical company or healthcare provider.